EXPONENTIAL TALENT PODCAST
Hosted by Dr. Shreya Sarkar-Barney
The Importance of Courage in Leading Breakthroughs
Dr. Kenneth Barr
This is our exponential talent podcast on The Importance of Courage in Leading Breakthroughs, with Dr. Ken Barr. Life presents many occasions to show up courageously and when we seize the moment it can make the difference between success and failure. Hope you find value in the lessons Ken shares. There are many takeaways, particularly for leaders who work in cross-border teams.
- By subscribing you receive notification when a new podcast is released and gain access to the podcast transcript
About Our Courage in Leading Episode
Your courage in addressing the elephant in the room led to breakthroughs in performance leading to long-term success for your organization. Would you share with us, what does courage mean to you?
Exercising courage could potentially lead to unpopularity. You have had the unique distinction of being courageous and being extremely loved by your teams. How did you achieve that?
As someone who has led various drug discovery teams around the world, what have you learned about leading virtual teams?
Is there a difference between leading teams in Hungary vs. India vs. China? What advice do you have for anyone leading culturally diverse teams?
Team leadership is closely related to innovation. In your experience, what specific team leader behaviors lead to innovation success. Could you also comment on the team characteristics that you have found to be important for innovation?
Today’s episode topic is on courage in leadership practices. Kicking off this topic, as well as our series anniversary episode, is Dr. Ken Barr. Dr. Barr is an acclaimed researcher who has led several drug discovery teams around the world. He is an MIT-trained Ph.D. in synthetic organic chemistry with several patents to his credit. Currently, he is the executive director and head of R&D Strategic Global Operations at FORMA therapeutics Inc. Previously, he was with Merck, Amplyx Pharmaceutical, Sunesis, and Abbott Labs.
We had the privilege of partnering with Dr. Barr on a project that resulted in the successful turnaround of a failing cross-border collaboration. In this podcast, we explore what it takes to lead under challenging circumstances. Listeners will learn about leading breakthroughs and the importance of courage in addressing the elephant in the room. If you have wondered why some leaders are better in shepherding transformations than others, this podcast presents several answers.
Meet the Speaker From Our Podcast on Courage in Leading Episode
Dr. Ken Barr, an acclaimed researcher who has led several drug discovery teams around the world. He is an MIT-trained Ph.D. in synthetic organic chemistry with several patents to his credit. He is currently the executive director and head of R&D Strategic Global Operations at FORMA therapeutics Inc. Previously, he was with Merck, Amplyx Pharmaceutical, Sunesis, and Abbott Labs.